Previous studies with overexpressing wi
ld-type or dominant negative nonvisua
l arrestins haveestab
lished a ro
le for these proteins in
le">
2-adrenergic receptor (
le">
2AR) interna
lization, desensitization, andresensitization. To va
lidate and extend such findings, we emp
loyed an antisense strategy to target thenonvisua
l arrestins, arrestin-2 and arrestin-3, and determined the associated effects on the regu
lation of Gprotein-coup
led receptor (GPCR) signa
ling. HEK293 ce
lls stab
ly expressing antisense constructs targetingarrestin-2 exhibited a se
lective reduction (~50%) in arrestin-2
leve
ls, whi
le arrestin-3 antisense constructsresu
lted in reductions (
50%) in both arrestin-2 and arrestin-3
leve
ls. Initia
l ana
lysis of these ce
llsdemonstrated that a reduced
leve
l of arrestin expression resu
lted in a significant decrease in the extent ofagonist-induced interna
lization of exogenous
ly expressed
le">
2ARs, but had no effect on interna
lization ofeither m2 or m3 muscarinic acety
lcho
line receptors. Additiona
l characterization invo
lved assessing thero
le of arrestins in the regu
lation of endogenous GPCRs in these ce
lls. Reduced arrestin
leve
ls significant
lydecreased the rate of endogenous
le">
2AR interna
lization, desensitization, and resensitization. Further ana
lysisdemonstrated that the desensitization of endogenous A
2b adenosine and prostag
landin E
2-stimu
lated receptorswas a
lso attenuated in ce
lls with reduced arrestin
leve
ls. The effects on the
le">
2-adrenergic, A
2b adenosine,and PGE
2-stimu
lated receptors were simi
lar among ce
ll lines that exhibited either a se
lective reduction inarrestin-2
leve
ls or a reduction in both arrestin-2 and -3
leve
ls. These findings estab
lish the uti
lity ofantisense approaches in the examination of arrestin-mediated GPCR regu
lation.